JENN PAUL 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Dec 15, 2005
Insider Transaction Report
Form 4
JENN PAUL
VP of Product Development
Transactions
- Award
Common Stock
[F1]2005-12-14+65,654→ 71,328 total
Footnotes (1)
- [F1]Restricted stock grant pursuant to that certain Retention Agreement, dated October 6, 2005.
Signature
/s/ Gail A. Sloan
Attorney-in-fact for Paul C. Jenn|2005-12-15